NUVI gives the markets what they crave

Good morning, Roachland!

Emo Capital Corp. (NUVI) does its business under the “NuVitality” brand — one of the up and coming names in the “superfood” world.

What’s a “superfood?” Your Papa will tell you down below. Up here, all you need to know is that the market is crazy for superfoods.

You know Monavie…what if you could TRADE it?

NUVI’s products have all the berries and vitamins and lucrative direct marketing network that made the Wall Street Journal tout Monavie as a billion-dollar opportunity. (Read more)

You can’t even trade Monavie, much less get in on the ground floor, but even a look at that chart shows you the market will “settle” for NUVI!

And as a bonus, NUVI came up with two big twists on the billion-dollar model.
First, its formulas are a generation more advanced with plenty of scientific studies to show that they really do help people lose weight, treat psoriasis and in general dump the poisons of modern life.

Second, NUVI is building its franchise by offering customers CASH BACK for trying the program! (Read more)

NUVI estimates that just the weight loss piece alone…just in the United States…can be worth $60 BILLION a year to the right company. (Read more)

Not to mention places like Australia and New Zealand, where NUVI expects to capture a slice of hundreds of millions of added dollars. (Read more)

Roaches know the “ground floor” NUVI is operating on!

Just 0.0015% of the market opportunity could net NUVI $15 million this year. (Read more)

That’s actually a stunning number when you consider there are only 5 million NUVI shares on the market…currently bid at $0.66 apiece. (Read more)

And this big ball has just gotten rolling! NUVI only started accepting orders on its website 2 weeks ago! (Read more)

This is history in the making, my children!

Take a look at NUVI this morning, and maybe you’ll make a little “history” yourself!

Papa Roach

 

 

Jason Bond’s strategy has made over $156,000 in 10 months, isn’t it time you join him?

 

 

 

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. StockRoach.com is a wholly-owned subsidiary of StockHideout, LLC. BlueWave Advisors has been compensated twenty thousand dollars from Equities AG (a non-controlling third party shareholder) for NUVI advertising and promotion. StockHieout LLC has been compensated seven thousand five hundred dollars from BlueWave Advisors (a non-affiliated third party) for NUVI advertising and promotion. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. StockHideout, LLC and its affiliates currently hold no shares in the profiled company. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Leave a Response